Key Events This Week
11 May: Stock opens at Rs.120.65, marginal gain despite Sensex decline
12 May: Sharp 5.68% drop following downgrade to Sell rating
13 May: Quarterly results show profit rebound but revenue decline; stock rallies 3.95%
14 May: Reports flat quarterly performance amid margin pressures; stock slips 1.86%
15 May: Week closes at Rs.115.00, down 0.95% on the day
Are Smruthi Organics Ltd latest results good or bad?
2026-05-14 19:19:39Smruthi Organics Ltd's latest financial results reveal a complex picture characterized by both sequential recovery and underlying challenges. In the quarter ended March 2026, the company reported net sales of ₹29.09 crores, reflecting a quarter-on-quarter growth of 30.51% from ₹22.29 crores in the previous quarter. However, this figure represents a significant year-on-year decline of 23.63% compared to ₹38.09 crores in the same quarter of the prior year, indicating persistent difficulties in revenue generation. The net profit for the same quarter stood at ₹1.07 crores, which is a decrease of 52.02% year-on-year. This decline in profitability is compounded by a higher effective tax rate, which surged to 38.51% in Q4 FY26, compared to 18.32% in the prior year. The operating margin for the quarter was reported at 13.03%, showing a modest year-on-year improvement of 0.77% but a notable contraction from the pre...
Read full news article
Smruthi Organics Ltd Reports Flat Quarterly Performance Amid Margin Pressures
2026-05-14 08:00:07Smruthi Organics Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has reported a flat financial performance for the quarter ended March 2026, signalling a notable shift from its previously positive growth trajectory. Despite a higher profit after tax (PAT) for the nine-month period, the company’s net sales have contracted sharply, prompting a downgrade in its Mojo Grade from Hold to Sell.
Read full news article
Smruthi Organics Q4 FY26: Profit Rebounds But Revenue Slide Continues
2026-05-13 20:46:47Smruthi Organics Ltd., a micro-cap pharmaceutical company with a market capitalisation of ₹130.00 crores, reported a sequential recovery in profitability for the quarter ending March 2026, though the underlying revenue trends remain concerning. Net profit for Q4 FY26 stood at ₹1.07 crores, marking a decline of 23.60% quarter-on-quarter from ₹1.40 crores in Q3 FY26, whilst representing a sharp 52.02% decline year-on-year from ₹2.23 crores in Q4 FY25.
Read full news article
Smruthi Organics Ltd Downgraded to Sell Amid Mixed Financial and Technical Signals
2026-05-13 08:25:57Smruthi Organics Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 12 May 2026. This shift reflects a combination of deteriorating technical indicators, subdued long-term financial growth, and valuation concerns despite some recent positive earnings momentum. The company’s Mojo Score now stands at 48.0, signalling caution for investors amid a challenging market backdrop.
Read full news articleWhen is the next results date for Smruthi Organics Ltd?
2026-05-07 23:16:52The next results date for Smruthi Organics Ltd is scheduled for 13 May 2026....
Read full news article
Smruthi Organics Ltd Upgraded to Hold as Technicals Improve and Financials Strengthen
2026-05-05 08:40:56Smruthi Organics Ltd has seen its investment rating upgraded from Sell to Hold as of 4 May 2026, reflecting a nuanced improvement across technical indicators, valuation metrics, financial performance, and quality assessments. This upgrade comes amid a micro-cap pharmaceutical sector backdrop where the company’s recent quarterly results and technical signals have shifted investor sentiment, warranting a closer examination of the factors driving this change.
Read full news article
Smruthi Organics Ltd Downgraded to Sell Amid Mixed Financial and Technical Signals
2026-04-29 08:14:36Smruthi Organics Ltd has seen its investment rating downgraded from Hold to Sell as of 28 Apr 2026, reflecting a shift in technical indicators and concerns over its long-term growth prospects despite recent positive financial results. The company’s current Mojo Score stands at 48.0, with a micro-cap market capitalisation and a day-on-day price decline of 3.09%. This article analyses the four key parameters—Quality, Valuation, Financial Trend, and Technicals—that have influenced this rating change.
Read full news article
Smruthi Organics Ltd Upgraded to Hold as Technicals Improve and Financials Strengthen
2026-04-24 08:09:51Smruthi Organics Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a notable shift in technical indicators and improving financial metrics. The micro-cap pharmaceutical company’s recent performance and valuation adjustments have prompted analysts to revise their outlook, signalling cautious optimism amid mixed long-term growth trends.
Read full news article





